Literature DB >> 9698754

Histopathological diagnosis of intra- and extrahepatic neonatal cholestasis.

J L Santos1, H Almeida, C T Cerski, T R Silveira.   

Abstract

The histopathology of the liver is fundamental for the differential diagnosis between intra- and extrahepatic causes of neonatal cholestasis. However, histopathological findings may overlap and there is disagreement among authors concerning those which could discriminate between intra- and extrahepatic cholestasis. Forty-six liver biopsies (35 wedge biopsies and 11 percutaneous biopsies) and one specimen from a postmortem examination, all from patients hospitalized for neonatal cholestasis in the Pediatrics Service of Hospital de Clínicas de Porto Alegre, were prospectively studied using a specially designed histopathological protocol. At least 4 of 5 different stains were used, and 46 hepatic histopathological variables related to the differential diagnosis of neonatal cholestasis were studied. The findings were scored for severity on a scale from 0 to 4. Sections which showed less than 3 portal spaces were excluded from the study. Sections were examined by a pathologist who was unaware of the final diagnosis of each case. Bile tract permeability was defined by scintigraphy of the bile ducts and operative cholangiography. The F test and discriminant analysis were used as statistical methods for the study of the hepatic histopathological variables. The chi-square method with Yates correction was used to relate the age of the patients on the date of the histopathological study to the discriminatory variables between intra- and extrahepatic cholestasis selected by the discriminant function test. The most valuable hepatic histopathological variables for the discrimination between intra- and extrahepatic cholestasis, in decreasing order of importance, were periportal ductal proliferation, portal ductal proliferation, portal expansion, cholestasis in neoductules, foci of myeloid metaplasia, and portal-portal bridges. The only variable which pointed to the diagnosis of intrahepatic cholestasis was myeloid metaplasia. Due to the small number of patients who were younger than 60 days on the date of the histopathological study (N = 6), no variable discriminated between intra- and extrahepatic cholestasis before the age of 2 months and all of them, except for the portal expansion, were discriminatory after this age. In infants with cholestasis, foci of myeloid metaplasia, whenever present in the liver biopsy, suggested intrahepatic cholestasis. Periportal ductal proliferation, portal ductal proliferation, portal expansion, cholestasis in neoductules, portal cholestasis and portal-portal bridges suggested extrahepatic obstructive cholestasis.

Entities:  

Mesh:

Year:  1998        PMID: 9698754     DOI: 10.1590/s0100-879x1998000700005

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  4 in total

1.  Usefulness of a scoring system in the interpretation of histology in neonatal cholestasis.

Authors:  Way Seah Lee; Lai Meng Looi
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

2.  Morphometric assessment of liver fibrosis may enhance early diagnosis of biliary atresia.

Authors:  Ahmed F Abdalla; Abeer Fathy; Khaled R Zalata; Ahmed Megahed; Ahmed Abo-Alyazeed; Mohammed Ezz El Regal
Journal:  World J Pediatr       Date:  2013-06-17       Impact factor: 2.764

3.  Analysis of the histologic features in the differential diagnosis of intrahepatic neonatal cholestasis.

Authors:  Maria Angela Bellomo-Brandao; Cecilia A F Escanhoela; Luciana R Meirelles; Gilda Porta; Gabriel Hessel
Journal:  World J Gastroenterol       Date:  2009-01-28       Impact factor: 5.742

4.  Congenital aflatoxicosis, mal-detoxification genomics & ontogeny trigger immune-mediated Kotb disease biliary atresia variant: SANRA compliant review.

Authors:  Magd A Kotb; Ahmed Kotb; Sahar Talaat; Sherif M Shehata; Nabil El Dessouki; Ahmed A ElHaddad; Gamal El Tagy; Haytham Esmat; Sameh Shehata; Mohamed Hashim; Hanan A Kotb; Hanan Zekry; Hesham M Abd Elkader; Sherif Kaddah; Hend E Abd El Baky; Nabil Lotfi
Journal:  Medicine (Baltimore)       Date:  2022-09-30       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.